AndreasKaubischMD

Oncology • Bronx, NY

Assistant Professor, Medicine, Oncology, Albert Einstein College of Medicine

Join to view full profile

Are you Dr. Kaubisch?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 109 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
MMC Dept of Oncology
111 East 210TH Street
Bronx, NY 10467
Phone+1 718-920-4057

Fax+1 718-798-7474

Summary

Dr. Andreas Kaubisch, MD is an oncologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with Montefiore Medical Center, St. Barnabas Hospital, and Burke Rehabilitation Hospital.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1992 - 1995
Columbia University Vagelos College of Physicians and SurgeonsClass of 1992

Certifications & Licensure

NY State Medical License 1994 - 2025

Clinical Trials

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 2
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer Start of enrollment: 2003 Jun 01
Terminated
Phase 1, Phase 2
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 2
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 1, Phase 2
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01
Terminated
Phase 2
FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
Completed
Phase 3
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer Start of enrollment: 2013 Apr 01
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Rece...
Herui Yao, Min Yan, Zhongsheng Tong, Xinhong Wu, Min-Hee Ryu
Journal of Clinical Oncology. 2024-10-10
2 citations
Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States.
Fernand Bteich, Kush Desai, Chenxin Zhang, Anahat Kaur, Rachel A Levy
Journal of Hepatocellular Carcinoma. 2024-01-01
1 citations
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg
Endocrine-Related Cancer. 2023-11-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member